Mobile health intervention for asthma management in young African American adults
Asthma and Technology in Emerging African American Adults (The ATHENA Project).
This study is testing a mobile health program to help young African American adults with asthma manage their condition better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 180 (estimated) |
| Ages | 18 Years to 30 Years |
| Sex | All |
| Sponsor | University of Michigan Academic / other |
| Locations | 3 sites (Tallahassee, Florida and 2 other locations) |
| Trial ID | NCT05445583 on ClinicalTrials.gov |
What this trial studies
The ATHENA Project aims to improve asthma management among African American young adults aged 18-30 through a mobile health intervention. This program includes a web-based asthma management app, video conferences with asthma nurses, text messaging support, and physical activity tracking. Participants will be randomly assigned to different components of the intervention to tailor the approach to their needs. The goal is to enhance asthma control and management behaviors, ultimately leading to better quality of life for participants.
Who should consider this trial
Good fit: Ideal candidates are African American young adults aged 18-30 with uncontrolled asthma.
Not a fit: Patients with significant cardiopulmonary diseases or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve asthma control and management for young African American adults.
How similar studies have performed: Previous studies have shown promise in using mobile health interventions for asthma management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * African American, 18-30 years of age, uncontrolled asthma (defined by a score of less than 19 on the ACT), own or have access to a cell phone for the duration of the study, have a primary care physician (PCP) Exclusion Criteria: * Significant cardiopulmonary disease (including chronic obstructive pulmonary disease), a greater than 20 pack per year smoking history, developmental delay or mental illness such that participation in the program would not be possible, pregnancy
Where this trial is running
Tallahassee, Florida and 2 other locations
- Florida State University — Tallahassee, Florida, United States (Not_yet_recruiting)
- University of Michigan — Ann Arbor, Michigan, United States (Recruiting)
- Wayne State University — Detroit, Michigan, United States (Not_yet_recruiting)
Study contacts
- Principal investigator: Alan Baptist, MD. — University of Michigan
- Study coordinator: Alan Baptist, MD.
- Email: abaptist@med.umich.edu
- Phone: 734-936-5634
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.